Prescribing for OA patients: new guide

The International NSAID Consensus Group, which developed the guidelines, said patients at risk of GI and cardiovascular (CV) events should have preventive strategies in place, such as inclusion of the lowest effective dose of NSAID, co-therapy with a gastroprotective drug, or the use of a COX-2 selective agent to optimise treatment outcomes.